Paloma Pharmaceuticals have announced positive results with a small molecule inhibitor of the P13K/Akt/mTOR pathway implicated in a wide variety of biological responses.
Paloma Pharmaceuticals have announced positive results with a small molecule inhibitor of the P13K/Akt/mTOR pathway implicated in a wide variety of biological responses.